Fascination About modafinil

Fascination About modafinil

Blog Article

Belzutifan is usually a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors may perhaps increase incidence or severity of adverse outcomes. Watch for anemia and hypoxia and reduce belzutifan dose as encouraged.

Stay clear of or Use Alternate Drug. Stay away from coadministration of delicate CYP3A4 substrates with ivosidenib or change with option therapies. If coadministration is unavoidable, watch people for lack of therapeutic effect of those medicine.

Identify your selection: Identify have to be a lot less than characters Decide on a set: Unable to load your selection resulting from an error

crofelemer will increase levels of modafinil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Crofelemer has the potential to inhibit CYP3A4 at concentrations expected during the intestine; unlikely to inhibit systemically due to the fact minimally absorbed.

No precise dose adjustment suggested when tofacitinib coadministered with potent CYP2C19 inhibitors; reduce tofacitinib dose if coadministered with both equally average CYP3A4 and potent CYP2C19 inhibitors .

apalutamide will lower the level or influence of modafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration of apalutamide, a strong CYP3A4 inducer, with medications that are CYP3A4 substrates can result in lower exposure to these drugs.

Additionally they identified that the dopamine autoreceptor agonist quinpirole attenuated the effects of modafinil in DSP-four dealt with mice, indicating a job for dopamine in modafinil’s wake-endorsing effects. As such, the authors recommended that modafinil labored through an increase in dopamine tone and dopamine’s stimulation with the αone adrenergic receptor.

Prescription drugs that have amount boundaries connected with Each and every prescription. This restriction commonly limits the amount of the drug that can be coated.

Keep track of Intently (one)crofelemer raises amounts of modafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Crofelemer has the possible to inhibit CYP3A4 at concentrations envisioned inside the gut; unlikely to inhibit systemically simply because minimally absorbed.

drospirenone will enhance the level or result of modafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.

carbamazepine will lower the level or effect of modafinil by influencing hepatic/intestinal enzyme more information CYP3A4 metabolism. Use Warning/Check.

Small (one)modafinil will enhance the amount or effect of lansoprazole by affecting hepatic enzyme CYP2C19 metabolism. Small/Significance Unfamiliar. Net effect on pantoprazole actions unfamiliar resulting from opposing outcomes of CYP450 enzymes; monitor

danazol will enhance the amount or outcome of modafinil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.

tazemetostat will minimize the extent or influence of modafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.